Innogene Kalbiotech was incorporated in 2003 as a subsidiary of PT Kalbe Farma Tbk (Kalbe), which was established in 1966. Today, Kalbe is the largest publicly-listed pharmaceutical company in Southeast Asia and was named one of the “Most Admired Companies” in 2014 by Fortune Indonesia. At Kalbe, we are not just a pharmaceuticals manufacturer but a provider of comprehensive healthcare solutions ranging from pharmaceuticals, nutrition, supplements, health foods and beverages to medical devices and primary healthcare services. We pride ourselves on building global brands with high sales potential in every business unit, to support growth. Kalbe currently has more than 20 subsidiaries and 10 production facilities of international standard, supported by more than 17,000 employees and 6,000 sales and marketing personnel spread over 68 branches across Indonesia and ASEAN. Awards: “The Most Innovative Biotech” Award in the 2nd Annual Biopharma Asia Industry Awards by BioPharma Asia in 2012 “2012 Frost & Sullivan Asia Pacific Fastest Growing Home-Grown Company in Oncology Care” by Frost & Sullivan Asia Pacific Best Practices Awards in 2012.
View Top Employees from Innogene Kalbiotech Pte. Ltd.Website | https://innogene-kalbiotech.com/index.php |
Revenue | $5 million |
Employees | 37 (21 on RocketReach) |
Founded | 2003 |
Industry | Biotechnology Research, Business Services General, Business Services |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 541713 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies |
Looking for a particular Innogene Kalbiotech Pte. Ltd. employee's phone or email?
The Innogene Kalbiotech Pte. Ltd. annual revenue was $5 million in 2024.
Saravanakumar NSK is the Head of Business Operations of Innogene Kalbiotech Pte. Ltd..
21 people are employed at Innogene Kalbiotech Pte. Ltd..
The NAICS codes for Innogene Kalbiotech Pte. Ltd. are [541, 541713, 5417, 54171, 54].
The SIC codes for Innogene Kalbiotech Pte. Ltd. are [87, 873].